Sugi Predict

Sugi Predict / Compounds / SCHEMBL1890200

SCHEMBL1890200

SCHEMBL1890200

CCOC(=O)n1nc(NC(=O)c2ccc(N3CCOCC3)cc2[N+](=O)[O-])c2c1CCN(S(=O)(=O)c1cc(F)cc(F)c1)C2

nearest known ligand 0.43

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ IGF1R P08069 2/20 0.43
▸ MAPT P10636 5/20 0.41
▸ ALDH1A1 P00352 2/20 0.41
▸ MEN1 O00255 2/20 0.38
▸ KMT2A Q03164 2/20 0.38
▸ SMN1; SMN2 Q16637 4/20 0.38
▸ HSD17B10 Q99714 2/20 0.38
▸ MAPK1 P28482 1/20 0.38
▸ NPSR1 Q6W5P4 1/20 0.38
▸ CREBBP Q92793 1/20 0.38
▸ LMNA P02545 2/20 0.37
▸ HPGD P15428 2/20 0.37
▸ KDM4E B2RXH2 1/20 0.37
▸ HTT P42858 1/20 0.37
▸ GAA P10253 1/20 0.36
▸ TP53 P04637 1/20 0.36
▸ TDP1 Q9NUW8 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1894731 0.93 IGF1R (0.50) IGF1RMAPTMEN1KMT2ALMNA
SCHEMBL1888067 0.90 IGF1R (0.42) IGF1RMAPTALDH1A1MEN1KMT2A
SCHEMBL1895721 0.89 IGF1R (0.45) IGF1RMAPTALDH1A1MEN1KMT2A
Hydrochloric Acid SCHEMBL1895719 0.89 IGF1R (0.45) IGF1RMAPTALDH1A1MEN1KMT2A
SCHEMBL1885175 0.87 IGF1R (0.38) IGF1RMAPTALDH1A1MEN1KMT2A
SCHEMBL1891290 0.87 IGF1R (0.45) IGF1RMAPTMEN1KMT2ALMNA
SCHEMBL1895529 0.87 ALDH1A1 (0.40) IGF1RMAPTALDH1A1MEN1KMT2A
SCHEMBL2460044 0.87 IGF1R (0.38) IGF1RMAPTALDH1A1MEN1KMT2A
SCHEMBL1892503 0.85 TMEM97 (0.44) IGF1RMAPTMEN1KMT2ASMN1; SMN2
SCHEMBL1890266 0.85 SIRT6 (0.42) IGF1RMAPTALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8173659-B2 Substituted pyrazolo[4,3-C]pyridine derivatives active as kinase inhibitors NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2012-05-08 — — US disclosed
US-20110230470-A1 SUBSTITUTED PYRAZOLO[4,3-C]PYRIDINE DERIVATIVES ACTIVE AS KINASE INHIBITORS NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2011-09-22 — — US disclosed
US-7947686-B2 Substituted pyrazolo[4,3-c]pyridine derivatives active as kinase inhibitors NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2011-05-24 — — US disclosed
US-20090023745-A1 Substituted Pyrazolo[4,3-c]Pyridine Derivatives Active as Kinase Inhibitors NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2009-01-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110230470-A1 SUBSTITUTED PYRAZOLO[4,3-C]PYRIDINE DERIVATIVES ACTIVE AS KINASE INHIBITORS MAP3K3, MAP3K1, MAP3K19 IGF1R 760/4885MAPT 2600/4885ALDH1A1 2295/4885
US-20090023745-A1 Substituted Pyrazolo[4,3-c]Pyridine Derivatives Active as Kinase Inhibitors MAP3K3, MAP3K1, MAP3K19 IGF1R 760/4885MAPT 2600/4885ALDH1A1 2295/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.